Elanco Animal Health INC Form 4 insider transactions

Elanco Animal Health Inc. director Kirk P. McDonald was granted 10,314 deferred stock units as part of an annual equity award for non-employee board members.

Elanco Animal Health Inc. Director Lawrence Kurzius was granted 10,314 deferred stock units as an annual equity award.

Elanco Animal Health Inc. director Deborah Turner Kochevar was granted 10,314 deferred stock units as an annual equity award.

Elanco Animal Health Inc. Director R. David Hoover was granted 10,314 shares of common stock as an annual equity award.

Elanco Animal Health Inc. Director Paul Herendeen was granted 10,314 deferred stock units as an annual equity award.

Elanco Animal Health Director Art A. Garcia was granted 10,314 deferred stock units as part of his annual equity award.

Elanco Animal Health Inc. Director Michael J. Harrington was granted 10,314 deferred stock units as an annual equity award.

Elanco EVP Rajeev A. Modi reported acquiring 67.0754 deferred stock units at $21.09, increasing his DSU holdings to 7,230.2452.

Elanco CEO Jeffrey N. Simmons acquired 131.3058 deferred stock units at $21.09 and now directly holds 18,355.9214 DSUs under the company’s Executive Deferral and Stock Match Plan.

Elanco Animal Health Inc's President and CEO, Jeffrey N. Simmons, acquired 125.0221 deferred stock units, increasing his beneficial ownership.

Elanco Animal Health's EVP, Rajeev A. Modi, reported the acquisition of 63.8655 deferred stock units, effective October 31, 2025, under a Rule 10b5-1 plan.

Jeffrey N. Simmons, Elanco Animal Health's President and CEO, acquired 129.2829 deferred stock units, increasing his total beneficial ownership to 18,099.5935 units.

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, acquired 66.042 deferred stock units on October 17, 2025, increasing his beneficial ownership to 7,099.3043 units.

Elanco Animal Health Inc. Executive Vice President Rajeev A. Modi acquired 68.5378 deferred stock units on October 3, 2025.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 134.1686 deferred stock units, increasing his beneficial ownership to 17,970.3106 units.

Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, was granted 109,857 restricted stock units and 53,869 stock options.

Elanco Animal Health Director Kapila K. Anand deferred cash retainer fees into 428.2522 deferred stock units, increasing her beneficial ownership to 8,513.6102 units.

Jeffrey N. Simmons, Elanco Animal Health's President and CEO, acquired 144.2313 deferred stock units, increasing his total beneficial ownership to 17,836.142 units.

Rajeev A. Modi, Elanco Animal Health's Executive Vice President, acquired 73.6781 deferred stock units, increasing his beneficial ownership to 6,964.7245 units.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 150.2572 deferred stock units, increasing his beneficial ownership.

Elanco Animal Health Inc's Executive Vice President, Rajeev A. Modi, acquired 76.7564 deferred stock units at a price of $18.43 per unit.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 154.6198 deferred stock units, increasing his beneficial ownership.

Rajeev A. Modi, Elanco's EVP, acquired 78.9849 deferred stock units, increasing his beneficial ownership to 6,814.29 units.

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, acquired 166.1212 deferred stock units at a price of $16.67 per unit.

Elanco Animal Health Inc. Executive Vice President Rajeev A. Modi acquired 84.8602 deferred stock units, aligning executive incentives with company performance.

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, acquired 185.6059 deferred stock units, increasing his beneficial ownership to 17,220.9125 units.

Elanco Animal Health Inc. Executive Vice President Rajeev A. Modi acquired 94.8137 deferred stock units, increasing his beneficial ownership to 6,650.4449 units.

Elanco Animal Health Inc. Executive Vice President Rajeev A. Modi acquired 94.9409 deferred stock units, increasing his beneficial ownership to 6,555.6312 units.

Elanco Animal Health Inc.'s President, CEO, and Director, Jeffrey N. Simmons, has filed a Form 4 indicating a future acquisition of 185.855 deferred stock units on July 11, 2025, under a pre-arranged plan.

Elanco Animal Health Inc.'s Chief Accounting Officer, James M. Meer, disposed of 1,161 shares of common stock on July 3, 2025, to cover tax obligations related to vested restricted stock units.